Monograph Details
|
|
Respiratory Tract
> Cough and cold
|
|
BRONTEX |
| Manufacturer |
|
Kenwood Laboratories |
| Legal Classification |
|
CIII |
| Pharmacological Class |
|
Antitussive + expectorant. |
| Generic Name |
|
Codeine phosphate 10mg, guaifenesin 300mg; tabs. |
| Also |
|
• BRONTEX LIQUID
|
| Indications |
|
Nonproductive cough. |
| Children |
|
<6 yrs: not recommended. 6–12 yrs: use liquid. |
| Adults |
|
1 tab every 4 hours as needed. |
| Contraindications |
|
Asthma. |
| Precautions |
|
Increased intracranial pressure. Head injury. Respiratory impairment. Pulmonary, renal or hepatic dysfunction. Very young. Seizures. Fever. Acute abdomen. Hypothyroidism. Addison's disease. Ulcerative colitis. GI or urinary obstruction. Children with atopy. Acute alcoholism. Drug abusers. Elderly. Debilitated. Pregnancy (Cat.C). Labor and delivery, nursing mothers: not recommended. |
| Interactions |
|
Potentiates alcohol, other CNS depressants, tranquilizers, antidepressants (esp. MAOIs). |
| Adverse Reactions |
|
Respiratory depression, sedation, drowsiness, dizziness, dysphoria, constipation, GI disturbances, hypertension, orthostatic hypotension, palpitations, urinary retention, blurred vision, anxiety. |
| How Supplied |
Tabs—100
Liquid—pt |
|
|
|
|
